Benjamin Carcamo
Pediatric Hematology-Oncology · El Paso, TXNPI 1437362092
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations.
Across 86 payments — averaging $59.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Pharmaceuticals LLC$875
- Jazz Pharmaceuticals Inc.$776
- Fennec Pharmaceuticals, Inc.$386
- Syndax Pharmaceuticals, Inc.$352
- AstraZeneca$283
- Agios Pharmaceuticals, Inc.$283
- plus $2K from 17 others
Across 4 payments — averaging $5250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$21K
What the payments were for
- Food & beverage$5,05499%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Pharmaceuticals LLC | 13 | $875 |
| Jazz Pharmaceuticals Inc. | 13 | $776 |
| Fennec Pharmaceuticals, Inc. | 13 | $386 |
| Syndax Pharmaceuticals, Inc. | 4 | $352 |
| AstraZeneca | 4 | $283 |
| Agios Pharmaceuticals, Inc. | 3 | $283 |
| Amgen(2 entities) | 4 | $281 |
| Novo Nordisk | 5 | $237 |
| Genentech USA, Inc. | 3 | $174 |
| USWM, LLC | 3 | $157 |
| Genentech, Inc. | 1 | $148 |
| Octapharma USA, Inc. | 2 | $145 |
| Adaptive Biotechnologies Corporation | 1 | $128 |
| Shire North American Group Inc | 2 | $127 |
| HEMA Biologics, LLC | 1 | $125 |
| Sanofi | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $108 |
| Novartis | 2 | $97 |
| United Therapeutics Corporation | 1 | $97 |
| Pharming Healthcare, Inc. | 1 | $77 |
| Springworks Therapeutics, Inc. | 1 | $59 |
| Medtronic | 1 | $35 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,084 in reported general payments places this provider in the 80th percentile of 235 pediatric hematology-oncology providers in Texas.
Other pediatric hematology-oncology in El Paso
- Prasad MathewEl Paso$153K
- Roberto CanalesEl Paso$3K
- Stanton GoldmanDallas$234K
- Vivek SubbiahHouston$194K
- Maurizio GhisoliDallas$174K
- Anish RayFort Worth$164K
- Joel WeinthalDallas$161K
- Vinod Gidvani-DiazSan Antonio$101K
- Kelly VallanceFort Worth$82K
- Scott PenneySan Antonio$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.